25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biomarin Pharmaceutical Inc
Buy, Hold or Sell?

Let's analyze Biomarin together

I guess you are interested in Biomarin Pharmaceutical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biomarin Pharmaceutical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biomarin Pharmaceutical Inc

I send you an email if I find something interesting about Biomarin Pharmaceutical Inc.

1. Quick Overview

1.1. Quick analysis of Biomarin (30 sec.)










1.2. What can you expect buying and holding a share of Biomarin? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$27.46
Expected worth in 1 year
$29.30
How sure are you?
77.5%

+ What do you gain per year?

Total Gains per Share
$1.84
Return On Investment
2.8%

For what price can you sell your share?

Current Price per Share
$66.16
Expected price per share
$61.15 - $67.95
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biomarin (5 min.)




Live pricePrice per Share (EOD)
$66.16
Intrinsic Value Per Share
$13.47 - $39.91
Total Value Per Share
$40.93 - $67.37

2.2. Growth of Biomarin (5 min.)




Is Biomarin growing?

Current yearPrevious yearGrowGrow %
How rich?$5.4b$4.7b$445.7m8.6%

How much money is Biomarin making?

Current yearPrevious yearGrowGrow %
Making money$80.5m$36.7m$43.8m54.4%
Net Profit Margin11.5%6.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Biomarin (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#21 / 949

Most Revenue
#25 / 949

Most Profit
#23 / 949

Most Efficient
#102 / 949
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biomarin?

Welcome investor! Biomarin's management wants to use your money to grow the business. In return you get a share of Biomarin.

First you should know what it really means to hold a share of Biomarin. And how you can make/lose money.

Speculation

The Price per Share of Biomarin is $66.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biomarin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biomarin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $27.46. Based on the TTM, the Book Value Change Per Share is $0.46 per quarter. Based on the YOY, the Book Value Change Per Share is $0.41 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biomarin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.540.8%0.410.6%0.190.3%0.360.5%0.040.1%
Usd Book Value Change Per Share1.091.7%0.460.7%0.410.6%0.570.9%0.490.7%
Usd Dividend Per Share0.000.0%0.000.0%0.120.2%0.030.0%0.010.0%
Usd Total Gains Per Share1.091.7%0.460.7%0.530.8%0.590.9%0.500.8%
Usd Price Per Share70.29-84.10-93.97-86.89-89.88-
Price to Earnings Ratio32.66-86.80--4,882.40--948.25--553.84-
Price-to-Total Gains Ratio64.26-99.08-436.06-60.28--55.14-
Price to Book Ratio2.56-3.21-3.83-3.92-5.45-
Price-to-Total Gains Ratio64.26-99.08-436.06-60.28--55.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share66.16
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share0.460.57
Usd Total Gains Per Share0.460.59
Gains per Quarter (15 shares)6.918.89
Gains per Year (15 shares)27.6635.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10281823426
20554636862
308374510298
401111026136134
501381308170170
6016615810204206
7019418611238242
8022121413272278
9024924214306314
10027727016340350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.03.00.075.0%15.05.00.075.0%17.023.00.042.5%28.075.00.027.2%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%17.03.00.085.0%30.010.00.075.0%67.035.01.065.0%
Dividend per Share0.00.04.00.0%5.00.07.041.7%5.00.015.025.0%5.00.035.012.5%5.00.098.04.9%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%18.02.00.090.0%31.09.00.077.5%68.034.01.066.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biomarin Pharmaceutical Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.0940.461+137%0.411+166%0.566+93%0.489+124%
Book Value Per Share--27.45926.274+5%24.567+12%22.741+21%18.238+51%
Current Ratio--4.2718.796-51%4.226+1%5.138-17%4.393-3%
Debt To Asset Ratio--0.2100.250-16%0.275-24%0.286-27%0.319-34%
Debt To Equity Ratio--0.2660.335-21%0.380-30%0.405-34%0.475-44%
Dividend Per Share----0%0.122-100%0.026-100%0.013-100%
Enterprise Value--13350107630.00015908313829.750-16%17498239324.480-24%16126601842.270-17%16663929949.911-20%
Eps--0.5380.406+33%0.190+184%0.361+49%0.035+1418%
Ev To Ebitda Ratio--21.33840.244-47%159.618-87%60.911-65%11.205+90%
Ev To Sales Ratio--4.4755.840-23%7.602-41%7.692-42%11.235-60%
Free Cash Flow Per Share--1.0160.379+168%0.042+2336%0.137+640%-0.105+110%
Free Cash Flow To Equity Per Share---1.516-0.278-82%0.018-8587%0.042-3693%0.075-2114%
Gross Profit Margin---0.027-1.177+4329%124.251-100%25.327-100%13.330-100%
Intrinsic Value_10Y_max--39.909--------
Intrinsic Value_10Y_min--13.469--------
Intrinsic Value_1Y_max--1.124--------
Intrinsic Value_1Y_min---0.121--------
Intrinsic Value_3Y_max--5.568--------
Intrinsic Value_3Y_min--0.908--------
Intrinsic Value_5Y_max--12.654--------
Intrinsic Value_5Y_min--3.323--------
Market Cap12608971809.280-10%13857462630.00016566400580.000-16%18110176824.480-23%16750926092.320-17%17226280874.936-20%
Net Profit Margin--0.1420.115+23%0.062+129%0.132+7%-0.034+124%
Operating Margin--0.1840.146+26%0.053+250%0.029+534%-0.058+131%
Operating Ratio--0.8470.888-5%0.952-11%0.985-14%1.079-21%
Pb Ratio2.409-6%2.5603.212-20%3.832-33%3.921-35%5.454-53%
Pe Ratio30.739-6%32.65886.799-62%-4882.399+15050%-948.248+3004%-553.838+1796%
Price Per Share66.160-6%70.29084.095-16%93.973-25%86.888-19%89.885-22%
Price To Free Cash Flow Ratio16.279-6%17.295-25.977+250%-21.913+227%-114.864+764%-142.112+922%
Price To Total Gains Ratio60.489-6%64.26599.081-35%436.061-85%60.282+7%-55.138+186%
Quick Ratio--2.7435.953-54%3.338-18%3.951-31%3.681-25%
Return On Assets--0.0150.012+33%0.006+177%0.011+36%-0.002+115%
Return On Equity--0.0200.015+28%0.008+154%0.016+19%-0.004+123%
Total Gains Per Share--1.0940.461+137%0.533+105%0.593+84%0.502+118%
Usd Book Value--5413396000.0005181265000.000+4%4735480750.000+14%4391550300.000+23%3504714075.000+54%
Usd Book Value Change Per Share--1.0940.461+137%0.411+166%0.566+93%0.489+124%
Usd Book Value Per Share--27.45926.274+5%24.567+12%22.741+21%18.238+51%
Usd Dividend Per Share----0%0.122-100%0.026-100%0.013-100%
Usd Enterprise Value--13350107630.00015908313829.750-16%17498239324.480-24%16126601842.270-17%16663929949.911-20%
Usd Eps--0.5380.406+33%0.190+184%0.361+49%0.035+1418%
Usd Free Cash Flow--200305000.00075220500.000+166%7822000.000+2461%26788150.000+648%-19745300.000+110%
Usd Free Cash Flow Per Share--1.0160.379+168%0.042+2336%0.137+640%-0.105+110%
Usd Free Cash Flow To Equity Per Share---1.516-0.278-82%0.018-8587%0.042-3693%0.075-2114%
Usd Market Cap12608971809.280-10%13857462630.00016566400580.000-16%18110176824.480-23%16750926092.320-17%17226280874.936-20%
Usd Price Per Share66.160-6%70.29084.095-16%93.973-25%86.888-19%89.885-22%
Usd Profit--106080000.00080572750.000+32%36755250.000+189%71058300.000+49%7605650.000+1295%
Usd Revenue--745740000.000687359500.000+8%577761500.000+29%539007900.000+38%426823900.000+75%
Usd Total Gains Per Share--1.0940.461+137%0.533+105%0.593+84%0.502+118%
 EOD+4 -4MRQTTM+25 -13YOY+24 -165Y+24 -1610Y+25 -15

3.3 Fundamental Score

Let's check the fundamental score of Biomarin Pharmaceutical Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.739
Price to Book Ratio (EOD)Between0-12.409
Net Profit Margin (MRQ)Greater than00.142
Operating Margin (MRQ)Greater than00.184
Quick Ratio (MRQ)Greater than12.743
Current Ratio (MRQ)Greater than14.271
Debt to Asset Ratio (MRQ)Less than10.210
Debt to Equity Ratio (MRQ)Less than10.266
Return on Equity (MRQ)Greater than0.150.020
Return on Assets (MRQ)Greater than0.050.015
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Biomarin Pharmaceutical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.706
Ma 20Greater thanMa 5064.934
Ma 50Greater thanMa 10067.473
Ma 100Greater thanMa 20075.982
OpenGreater thanClose66.050
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Biomarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. It has license and collaboration agreements with Sarepta Therapeutics; Ares Trading S.A.; Catalyst Pharmaceutical Partners, Inc.; and CAMP4 Therapeutics Corporation. The company was incorporated in 1996 and is headquartered in San Rafael, California.

Fundamental data was last updated by Penke on 2024-12-05 14:26:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biomarin earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biomarin to the Biotechnology industry mean.
  • A Net Profit Margin of 14.2% means that $0.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biomarin Pharmaceutical Inc:

  • The MRQ is 14.2%. The company is making a huge profit. +2
  • The TTM is 11.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.2%TTM11.5%+2.7%
TTM11.5%YOY6.2%+5.3%
TTM11.5%5Y13.2%-1.7%
5Y13.2%10Y-3.4%+16.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.2%-108.0%+122.2%
TTM11.5%-218.6%+230.1%
YOY6.2%-210.1%+216.3%
5Y13.2%-339.1%+352.3%
10Y-3.4%-464.5%+461.1%
4.3.1.2. Return on Assets

Shows how efficient Biomarin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biomarin to the Biotechnology industry mean.
  • 1.5% Return on Assets means that Biomarin generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biomarin Pharmaceutical Inc:

  • The MRQ is 1.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.2%+0.4%
TTM1.2%YOY0.6%+0.6%
TTM1.2%5Y1.1%+0.0%
5Y1.1%10Y-0.2%+1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%-11.3%+12.8%
TTM1.2%-11.8%+13.0%
YOY0.6%-11.3%+11.9%
5Y1.1%-12.6%+13.7%
10Y-0.2%-14.2%+14.0%
4.3.1.3. Return on Equity

Shows how efficient Biomarin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biomarin to the Biotechnology industry mean.
  • 2.0% Return on Equity means Biomarin generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biomarin Pharmaceutical Inc:

  • The MRQ is 2.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM1.5%+0.4%
TTM1.5%YOY0.8%+0.8%
TTM1.5%5Y1.6%-0.1%
5Y1.6%10Y-0.4%+2.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0%-14.2%+16.2%
TTM1.5%-15.9%+17.4%
YOY0.8%-14.4%+15.2%
5Y1.6%-18.5%+20.1%
10Y-0.4%-19.5%+19.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biomarin Pharmaceutical Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biomarin is operating .

  • Measures how much profit Biomarin makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biomarin to the Biotechnology industry mean.
  • An Operating Margin of 18.4% means the company generated $0.18  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biomarin Pharmaceutical Inc:

  • The MRQ is 18.4%. The company is operating efficient. +1
  • The TTM is 14.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ18.4%TTM14.6%+3.8%
TTM14.6%YOY5.3%+9.3%
TTM14.6%5Y2.9%+11.7%
5Y2.9%10Y-5.8%+8.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.4%-204.6%+223.0%
TTM14.6%-313.2%+327.8%
YOY5.3%-219.0%+224.3%
5Y2.9%-388.9%+391.8%
10Y-5.8%-495.6%+489.8%
4.3.2.2. Operating Ratio

Measures how efficient Biomarin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.85 means that the operating costs are $0.85 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biomarin Pharmaceutical Inc:

  • The MRQ is 0.847. The company is less efficient in keeping operating costs low.
  • The TTM is 0.888. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.847TTM0.888-0.041
TTM0.888YOY0.952-0.064
TTM0.8885Y0.985-0.097
5Y0.98510Y1.079-0.094
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8472.340-1.493
TTM0.8883.187-2.299
YOY0.9523.282-2.330
5Y0.9854.814-3.829
10Y1.0796.494-5.415
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biomarin Pharmaceutical Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biomarin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.27 means the company has $4.27 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biomarin Pharmaceutical Inc:

  • The MRQ is 4.271. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.796. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.271TTM8.796-4.525
TTM8.796YOY4.226+4.570
TTM8.7965Y5.138+3.658
5Y5.13810Y4.393+0.745
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2713.645+0.626
TTM8.7963.883+4.913
YOY4.2264.666-0.440
5Y5.1385.964-0.826
10Y4.3936.265-1.872
4.4.3.2. Quick Ratio

Measures if Biomarin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biomarin to the Biotechnology industry mean.
  • A Quick Ratio of 2.74 means the company can pay off $2.74 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biomarin Pharmaceutical Inc:

  • The MRQ is 2.743. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.953. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.743TTM5.953-3.210
TTM5.953YOY3.338+2.614
TTM5.9535Y3.951+2.002
5Y3.95110Y3.681+0.270
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7433.014-0.271
TTM5.9533.418+2.535
YOY3.3384.456-1.118
5Y3.9515.970-2.019
10Y3.6816.424-2.743
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biomarin Pharmaceutical Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biomarin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biomarin to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.21 means that Biomarin assets are financed with 21.0% credit (debt) and the remaining percentage (100% - 21.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biomarin Pharmaceutical Inc:

  • The MRQ is 0.210. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.250. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.210TTM0.250-0.040
TTM0.250YOY0.275-0.025
TTM0.2505Y0.286-0.037
5Y0.28610Y0.319-0.032
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2100.350-0.140
TTM0.2500.341-0.091
YOY0.2750.310-0.035
5Y0.2860.365-0.079
10Y0.3190.382-0.063
4.5.4.2. Debt to Equity Ratio

Measures if Biomarin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biomarin to the Biotechnology industry mean.
  • A Debt to Equity ratio of 26.6% means that company has $0.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biomarin Pharmaceutical Inc:

  • The MRQ is 0.266. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.335. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.266TTM0.335-0.069
TTM0.335YOY0.380-0.045
TTM0.3355Y0.405-0.071
5Y0.40510Y0.475-0.070
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2660.394-0.128
TTM0.3350.432-0.097
YOY0.3800.3800.000
5Y0.4050.451-0.046
10Y0.4750.490-0.015
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biomarin generates.

  • Above 15 is considered overpriced but always compare Biomarin to the Biotechnology industry mean.
  • A PE ratio of 32.66 means the investor is paying $32.66 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biomarin Pharmaceutical Inc:

  • The EOD is 30.739. Based on the earnings, the company is overpriced. -1
  • The MRQ is 32.658. Based on the earnings, the company is overpriced. -1
  • The TTM is 86.799. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD30.739MRQ32.658-1.919
MRQ32.658TTM86.799-54.141
TTM86.799YOY-4,882.399+4,969.198
TTM86.7995Y-948.248+1,035.047
5Y-948.24810Y-553.838-394.411
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD30.739-2.315+33.054
MRQ32.658-2.491+35.149
TTM86.799-3.156+89.955
YOY-4,882.399-3.274-4,879.125
5Y-948.248-6.037-942.211
10Y-553.838-6.785-547.053
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biomarin Pharmaceutical Inc:

  • The EOD is 16.279. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 17.295. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -25.977. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD16.279MRQ17.295-1.016
MRQ17.295TTM-25.977+43.273
TTM-25.977YOY-21.913-4.064
TTM-25.9775Y-114.864+88.887
5Y-114.86410Y-142.112+27.248
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD16.279-2.985+19.264
MRQ17.295-3.361+20.656
TTM-25.977-3.734-22.243
YOY-21.913-4.557-17.356
5Y-114.864-8.327-106.537
10Y-142.112-9.311-132.801
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biomarin is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.56 means the investor is paying $2.56 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biomarin Pharmaceutical Inc:

  • The EOD is 2.409. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.560. Based on the equity, the company is underpriced. +1
  • The TTM is 3.212. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.409MRQ2.560-0.150
MRQ2.560TTM3.212-0.652
TTM3.212YOY3.832-0.620
TTM3.2125Y3.921-0.709
5Y3.92110Y5.454-1.533
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.4091.919+0.490
MRQ2.5602.051+0.509
TTM3.2122.374+0.838
YOY3.8322.454+1.378
5Y3.9213.737+0.184
10Y5.4544.378+1.076
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biomarin Pharmaceutical Inc.

4.8.1. Institutions holding Biomarin Pharmaceutical Inc

Institutions are holding 97.727% of the shares of Biomarin Pharmaceutical Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc11.93090.042422738349825955957.0459
2024-09-30Vanguard Group Inc10.11560.0243192786542846161.4984
2024-09-30PRIMECAP Management Company9.89990.975118867435773500.4117
2024-09-30Dodge & Cox7.29250.552513898318-32175-0.231
2024-09-30Capital Research Global Investors5.50680.1533104949558023898.2784
2024-09-30Viking Global Investors LP5.11762.49889753293268972938.0789
2024-09-30State Street Corp4.62950.02528823114-812906-8.4361
2024-09-30Ameriprise Financial Inc2.24650.07724281482-419844-8.9303
2024-06-30NORGES BANK1.89920.044536195032581937.6813
2024-09-30Elliott Investment Management LP1.83661.2743350033800
2024-09-30Geode Capital Management, LLC1.71060.01853260050606921.897
2024-09-30JPMorgan Chase & Co1.47540.015128117892186088.4301
2024-09-30Bank of New York Mellon Corp1.21730.03032319989-18104-0.7743
2024-09-30venBio Select Advisor LLC1.06942.08882038015-2519401-55.2813
2024-06-30Deutsche Bank AG0.94820.06711807032-532204-22.7512
2024-09-30Northern Trust Corp0.77890.01711484358-93901-5.9497
2024-09-30Legal & General Group PLC0.77190.02161471049-47852-3.1504
2024-09-30Charles Schwab Investment Management Inc0.73540.01881401628556994.1383
2024-09-30Dimensional Fund Advisors, Inc.0.7030.0228133972130526429.5096
2024-09-30Nuveen Asset Management, LLC0.64170.0241122289516129315.1934
Total 70.52697.9918134411967+8697005+6.5%

4.9.2. Funds holding Biomarin Pharmaceutical Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Dodge & Cox Stock I4.67720.5422891402500
2024-09-30Vanguard PRIMECAP Inv3.8150.651672708082000002.8285
2024-11-27iShares Core S&P Mid-Cap ETF3.20760.39516113145119770.1963
2024-10-31Vanguard Total Stock Mkt Idx Inv3.1570.02296016631-22886-0.3789
2024-09-30Vanguard Capital Opportunity Inv2.9121.67415549780630001.1482
2024-09-30American Funds Growth Fund of Amer A2.60880.119749718363893978.4976
2024-09-30Capital Group Growth Fnd of Amer Comp2.60880.119749718363893978.4976
2024-09-30VA CollegeAmerica Amcap 529A2.41920.361846105203143297.3165
2024-09-30Capital Group AMCAP Composite2.41920.361846105203143297.3165
2024-10-31Vanguard Mid Cap Index Institutional2.11950.1522403935474500.1848
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.48510.17182830377-16028-0.5631
2024-03-31Aviva Investors GlConvtAbsRet I USD Acc1.308802494387-133343-5.0745
2024-10-31Vanguard Growth Index Investor1.27090.06082422185153550.638
2024-11-27SPDR® S&P Biotech ETF1.14681.92652185517-66330-2.9456
2024-09-30PRIMECAP Odyssey Aggressive Growth1.01811.92461940410-13370-0.6843
2024-09-30PRIMECAP Odyssey Growth0.8051.78531534256-78400-4.8615
2024-10-31SPDR® S&P MIDCAP 400 ETF Trust0.78570.4331497421-22051-1.4512
2024-10-31Vanguard Mid-Cap Growth ETF0.70530.3341134425735360.2637
2024-11-27iShares Biotechnology ETF0.68051.2176129689913180.1017
2024-10-31R-co Valor C EUR0.64581.36791230799-303-0.0246
Total 39.796313.622775844963+1357377+1.8%

5.3. Insider Transactions

Insiders are holding 0.882% of the shares of Biomarin Pharmaceutical Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-12Charles Greg GuyerSELL527866.37
2024-05-30Brian MuellerSELL500075.19
2024-05-28George Eric DavisSELL4085074.51
2024-05-09Jean Jacques BienaimeSELL2000081.62
2024-05-02George Eric DavisSELL185085.01
2024-04-12Jean Jacques BienaimeSELL2000091.26
2024-04-10Erin BurkhartSELL228690
2024-03-28George Eric DavisSELL2460288.34
2024-03-05Henry J FuchsSELL3534185.18
2024-03-05Jean Jacques BienaimeSELL100085.51
2024-03-05Jeffrey Robert AjerSELL400087.07
2024-02-27Jean Jacques BienaimeSELL100090.35
2024-02-09Jean Jacques BienaimeSELL1500088.28
2024-01-09Jean Jacques BienaimeSELL1000098.19
2023-12-21Jean Jacques BienaimeSELL1000093.99
2023-12-13George Eric DavisSELL1376495.3
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Net Debt  300,57031,275331,8459,121340,966-213,474127,492-200,253-72,761



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets6,851,195
Total Liabilities1,437,799
Total Stockholder Equity5,413,396
 As reported
Total Liabilities 1,437,799
Total Stockholder Equity+ 5,413,396
Total Assets = 6,851,195

Assets

Total Assets6,851,195
Total Current Assets3,056,590
Long-term Assets3,794,605
Total Current Assets
Cash And Cash Equivalents 675,448
Short-term Investments 254,996
Net Receivables 777,547
Inventory 1,179,339
Other Current Assets 169,260
Total Current Assets  (as reported)3,056,590
Total Current Assets  (calculated)3,056,590
+/-0
Long-term Assets
Property Plant Equipment 1,045,408
Goodwill 196,199
Long Term Investments 561,985
Intangible Assets 260,920
Long-term Assets Other 199,314
Long-term Assets  (as reported)3,794,605
Long-term Assets  (calculated)2,263,826
+/- 1,530,779

Liabilities & Shareholders' Equity

Total Current Liabilities715,658
Long-term Liabilities722,141
Total Stockholder Equity5,413,396
Total Current Liabilities
Short-term Debt 15,551
Accounts payable 312,321
Other Current Liabilities 371,891
Total Current Liabilities  (as reported)715,658
Total Current Liabilities  (calculated)699,763
+/- 15,895
Long-term Liabilities
Long term Debt 594,627
Capital Lease Obligations Min Short Term Debt-7,491
Long-term Liabilities Other 127,514
Long-term Liabilities  (as reported)722,141
Long-term Liabilities  (calculated)714,650
+/- 7,491
Total Stockholder Equity
Common Stock191
Retained Earnings -319,638
Accumulated Other Comprehensive Income 4,650
Other Stockholders Equity 5,728,193
Total Stockholder Equity (as reported)5,413,396
Total Stockholder Equity (calculated)5,413,396
+/-0
Other
Capital Stock191
Cash and Short Term Investments 930,444
Common Stock Shares Outstanding 197,147
Current Deferred Revenue2,346
Liabilities and Stockholders Equity 6,851,195
Net Debt -72,761
Net Invested Capital 6,008,023
Net Working Capital 2,340,932
Property Plant and Equipment Gross 1,914,616
Short Long Term Debt Total 602,687



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-31
> Total Assets 
26,800
51,400
112,500
103,549
94,490
86,090
83,324
76,933
65,443
98,321
90,402
171,811
171,811
141,973
127,469
110,616
183,117
306,385
284,446
256,340
239,296
347,416
312,230
232,966
180,933
167,247
208,842
195,303
488,229
468,714
467,072
463,436
449,764
781,639
791,056
815,279
827,702
854,555
859,038
906,695
900,283
844,437
869,357
917,163
966,205
985,516
1,244,533
1,262,623
1,264,146
1,280,392
1,295,076
1,303,681
1,297,085
1,532,527
1,567,376
1,601,643
1,598,293
1,601,520
1,620,530
2,249,217
2,340,728
2,345,685
2,440,433
2,490,453
3,658,686
3,648,689
3,624,853
3,729,368
3,666,993
3,087,304
3,842,238
4,023,690
3,938,607
4,019,965
4,580,697
4,633,125
4,596,717
4,624,679
4,695,254
4,427,128
4,435,398
4,393,384
4,558,128
4,690,039
4,722,841
5,302,110
6,158,090
5,848,020
5,805,053
5,898,496
5,977,475
6,003,325
6,062,707
6,145,841
6,264,040
6,375,074
6,433,695
6,563,172
6,758,163
6,841,603
6,872,673
7,067,121
6,851,195
6,851,1957,067,1216,872,6736,841,6036,758,1636,563,1726,433,6956,375,0746,264,0406,145,8416,062,7076,003,3255,977,4755,898,4965,805,0535,848,0206,158,0905,302,1104,722,8414,690,0394,558,1284,393,3844,435,3984,427,1284,695,2544,624,6794,596,7174,633,1254,580,6974,019,9653,938,6074,023,6903,842,2383,087,3043,666,9933,729,3683,624,8533,648,6893,658,6862,490,4532,440,4332,345,6852,340,7282,249,2171,620,5301,601,5201,598,2931,601,6431,567,3761,532,5271,297,0851,303,6811,295,0761,280,3921,264,1461,262,6231,244,533985,516966,205917,163869,357844,437900,283906,695859,038854,555827,702815,279791,056781,639449,764463,436467,072468,714488,229195,303208,842167,247180,933232,966312,230347,416239,296256,340284,446306,385183,117110,616127,469141,973171,811171,81190,40298,32165,44376,93383,32486,09094,490103,549112,50051,40026,800
   > Total Current Assets 
5,500
21,100
76,400
66,422
61,552
53,532
51,414
44,541
35,861
63,586
50,642
136,783
136,783
105,555
91,370
81,072
154,795
275,052
254,206
225,269
208,825
181,587
140,687
85,277
53,599
39,336
82,188
68,941
378,759
344,807
339,366
334,224
320,645
640,932
641,234
644,297
683,728
701,814
697,013
737,696
713,575
506,981
520,267
467,727
500,431
521,908
554,189
504,260
503,830
514,111
487,024
469,802
513,390
681,534
719,386
743,462
723,024
720,920
713,479
1,137,418
1,246,410
1,220,227
1,077,819
1,425,629
1,522,728
1,213,929
1,175,589
1,089,639
992,790
1,105,946
1,666,571
1,421,791
1,352,788
1,458,820
2,050,029
2,207,144
2,241,110
2,280,067
2,407,853
2,056,215
1,916,855
1,806,768
1,859,359
1,942,143
2,116,249
2,647,566
2,738,979
2,342,219
2,288,766
2,357,837
2,311,570
2,274,385
2,394,024
2,517,598
2,682,701
2,751,457
2,842,105
2,950,117
2,955,308
2,956,088
2,985,012
3,259,630
3,056,590
3,056,5903,259,6302,985,0122,956,0882,955,3082,950,1172,842,1052,751,4572,682,7012,517,5982,394,0242,274,3852,311,5702,357,8372,288,7662,342,2192,738,9792,647,5662,116,2491,942,1431,859,3591,806,7681,916,8552,056,2152,407,8532,280,0672,241,1102,207,1442,050,0291,458,8201,352,7881,421,7911,666,5711,105,946992,7901,089,6391,175,5891,213,9291,522,7281,425,6291,077,8191,220,2271,246,4101,137,418713,479720,920723,024743,462719,386681,534513,390469,802487,024514,111503,830504,260554,189521,908500,431467,727520,267506,981713,575737,696697,013701,814683,728644,297641,234640,932320,645334,224339,366344,807378,75968,94182,18839,33653,59985,277140,687181,587208,825225,269254,206275,052154,79581,07291,370105,555136,783136,78350,64263,58635,86144,54151,41453,53261,55266,42276,40021,1005,500
       Cash And Cash Equivalents 
3,600
17,200
32,600
23,413
40,675
10,609
16,098
16,530
19,722
18,967
7,230
12,528
12,528
19,363
32,405
33,638
125,835
221,772
187,978
121,406
96,199
48,247
34,981
13,081
11,246
17,111
56,213
38,092
341,689
285,990
191,782
89,162
98,331
205,010
291,825
228,343
319,990
252,209
271,217
222,900
214,579
200,050
191,778
167,171
108,963
115,779
127,539
88,079
90,782
112,956
71,254
46,272
82,586
177,757
181,330
180,527
154,380
175,445
181,565
568,781
639,778
584,717
398,005
875,486
900,570
440,664
376,346
397,040
270,453
305,969
707,349
408,330
348,234
354,864
431,399
598,028
473,980
427,411
882,184
493,982
364,369
307,577
423,220
437,446
476,632
818,900
1,015,675
649,158
667,313
641,533
617,143
587,276
605,440
619,802
761,515
724,531
580,074
694,381
785,414
755,127
746,996
972,150
675,448
675,448972,150746,996755,127785,414694,381580,074724,531761,515619,802605,440587,276617,143641,533667,313649,1581,015,675818,900476,632437,446423,220307,577364,369493,982882,184427,411473,980598,028431,399354,864348,234408,330707,349305,969270,453397,040376,346440,664900,570875,486398,005584,717639,778568,781181,565175,445154,380180,527181,330177,75782,58646,27271,254112,95690,78288,079127,539115,779108,963167,171191,778200,050214,579222,900271,217252,209319,990228,343291,825205,01098,33189,162191,782285,990341,68938,09256,21317,11111,24613,08134,98148,24796,199121,406187,978221,772125,83533,63832,40519,36312,52812,5287,23018,96719,72216,53016,09810,60940,67523,41332,60017,2003,600
       Short-term Investments 
300
300
39,600
39,573
14,999
38,803
31,407
23,671
10,044
40,918
36,675
118,569
118,569
81,195
54,063
40,340
22,743
44,588
53,911
84,951
94,999
80,549
51,570
35,734
18,513
9,574
9,700
9,700
6,000
19,910
102,118
199,685
174,976
382,700
294,861
357,251
254,772
323,448
291,752
336,892
337,290
146,341
171,566
133,506
214,679
221,894
224,428
186,033
161,799
145,964
153,120
148,820
150,393
224,829
245,125
270,211
247,502
225,116
198,086
215,942
247,703
251,901
268,368
69,706
108,119
240,889
241,984
195,579
186,400
197,318
327,499
381,347
329,821
372,912
825,700
797,940
908,815
935,662
561,192
590,326
530,485
423,526
297,572
316,361
381,764
561,472
489,998
416,228
420,178
481,864
462,333
426,599
450,798
489,945
512,253
567,006
572,017
476,577
340,431
318,683
299,584
252,201
254,996
254,996252,201299,584318,683340,431476,577572,017567,006512,253489,945450,798426,599462,333481,864420,178416,228489,998561,472381,764316,361297,572423,526530,485590,326561,192935,662908,815797,940825,700372,912329,821381,347327,499197,318186,400195,579241,984240,889108,11969,706268,368251,901247,703215,942198,086225,116247,502270,211245,125224,829150,393148,820153,120145,964161,799186,033224,428221,894214,679133,506171,566146,341337,290336,892291,752323,448254,772357,251294,861382,700174,976199,685102,11819,9106,0009,7009,7009,57418,51335,73451,57080,54994,99984,95153,91144,58822,74340,34054,06381,195118,569118,56936,67540,91810,04423,67131,40738,80314,99939,57339,600300300
       Net Receivables 
900
1,500
400
2,466
5,006
3,018
2,960
2,934
754
2,231
4,851
3,096
3,096
2,135
2,332
0
0
0
0
0
0
4,612
119
4,047
1,831
2,871
5,328
5,860
7,493
10,946
13,000
14,670
14,525
15,900
15,968
16,976
47,253
52,156
51,135
54,298
61,355
81,346
68,378
73,540
82,606
77,682
78,734
93,884
106,198
106,606
107,057
110,932
105,828
100,750
117,290
109,066
120,345
115,063
124,745
117,822
110,462
122,282
121,395
144,472
175,738
186,083
148,949
164,959
180,751
214,158
215,894
215,280
230,250
238,338
251,891
261,365
318,394
363,566
384,343
342,633
393,429
377,150
402,970
377,404
396,384
381,215
411,712
448,351
396,097
424,419
374,937
373,399
430,147
466,507
419,622
461,316
597,913
610,222
572,498
633,704
637,163
691,232
777,547
777,547691,232637,163633,704572,498610,222597,913461,316419,622466,507430,147373,399374,937424,419396,097448,351411,712381,215396,384377,404402,970377,150393,429342,633384,343363,566318,394261,365251,891238,338230,250215,280215,894214,158180,751164,959148,949186,083175,738144,472121,395122,282110,462117,822124,745115,063120,345109,066117,290100,750105,828110,932107,057106,606106,19893,88478,73477,68282,60673,54068,37881,34661,35554,29851,13552,15647,25316,97615,96815,90014,52514,67013,00010,9467,4935,8605,3282,8711,8314,0471194,6120000002,3322,1353,0963,0964,8512,2317542,9342,9603,0185,0062,4664001,500900
       Inventory 
100
800
900
676
647
495
446
436
439
480
525
0
0
0
0
0
0
0
0
0
0
2,074
3,090
2,316
2,439
3,386
7,720
10,898
18,137
24,247
25,762
25,075
27,438
30,714
31,551
32,445
54,736
61,802
68,094
73,162
76,423
72,836
75,441
78,662
79,761
83,778
91,741
109,698
110,067
112,299
115,628
130,118
124,064
120,125
120,825
128,695
135,822
142,296
148,684
162,605
176,893
193,498
204,444
199,452
222,833
237,532
262,100
271,683
296,979
326,556
347,420
355,126
384,143
429,831
457,393
475,775
468,161
473,356
508,482
530,871
534,696
578,736
609,049
680,275
705,652
743,852
700,847
698,548
713,929
710,975
749,406
776,669
786,356
802,315
839,460
894,083
918,921
975,546
1,032,159
1,107,183
1,137,982
1,183,621
1,179,339
1,179,3391,183,6211,137,9821,107,1831,032,159975,546918,921894,083839,460802,315786,356776,669749,406710,975713,929698,548700,847743,852705,652680,275609,049578,736534,696530,871508,482473,356468,161475,775457,393429,831384,143355,126347,420326,556296,979271,683262,100237,532222,833199,452204,444193,498176,893162,605148,684142,296135,822128,695120,825120,125124,064130,118115,628112,299110,067109,69891,74183,77879,76178,66275,44172,83676,42373,16268,09461,80254,73632,44531,55130,71427,43825,07525,76224,24718,13710,8987,7203,3862,4392,3163,0902,0740000000000525480439436446495647676900800100
       Other Current Assets 
600
1,300
2,900
294
225
607
503
970
3,386
990
1,361
2,590
2,590
2,862
2,570
7,094
6,217
8,692
12,317
18,912
17,627
20,981
25,729
4,801
6,640
6,275
3,227
4,391
5,440
3,714
6,704
5,632
5,375
6,608
7,029
9,282
6,977
12,199
14,815
50,444
23,928
239
13,104
14,848
14,422
22,775
31,747
235
34,984
36,286
39,965
4,994
50,519
58,073
54,816
25,509
35,501
33,526
28,161
41,707
41,013
37,268
56,458
105,310
84,265
77,558
115,330
60,378
58,207
61,945
68,409
61,708
60,340
62,875
83,646
74,036
71,760
80,072
71,652
98,403
93,876
119,779
126,548
130,657
155,817
142,127
120,747
129,934
91,249
99,046
107,751
110,442
121,283
139,029
149,851
104,521
173,180
193,391
224,806
141,391
163,287
160,426
169,260
169,260160,426163,287141,391224,806193,391173,180104,521149,851139,029121,283110,442107,75199,04691,249129,934120,747142,127155,817130,657126,548119,77993,87698,40371,65280,07271,76074,03683,64662,87560,34061,70868,40961,94558,20760,378115,33077,55884,265105,31056,45837,26841,01341,70728,16133,52635,50125,50954,81658,07350,5194,99439,96536,28634,98423531,74722,77514,42214,84813,10423923,92850,44414,81512,1996,9779,2827,0296,6085,3755,6326,7043,7145,4404,3913,2276,2756,6404,80125,72920,98117,62718,91212,3178,6926,2177,0942,5702,8622,5902,5901,3619903,3869705036072252942,9001,300600
   > Long-term Assets 
21,300
30,300
36,100
37,127
32,938
32,558
31,910
32,392
29,582
34,735
39,760
35,028
35,028
36,418
36,099
29,544
28,322
31,333
30,240
31,071
30,471
165,829
171,543
147,689
127,334
127,911
126,654
126,362
109,470
123,907
127,706
129,212
129,119
140,707
149,822
170,982
143,974
152,741
162,025
168,999
186,708
337,456
349,090
449,436
465,774
463,608
690,344
758,363
760,316
766,281
808,052
833,879
783,695
850,993
847,990
858,181
875,269
880,600
907,051
1,111,799
1,094,318
1,125,458
1,362,614
1,064,824
2,135,958
2,434,760
2,449,264
2,639,729
2,674,203
1,981,358
2,175,667
2,601,899
2,585,819
2,561,145
2,530,668
2,425,981
2,355,607
2,344,612
2,287,401
2,370,913
2,518,543
2,586,616
2,698,769
2,747,896
2,606,592
2,654,544
3,419,111
3,505,801
3,516,287
3,540,659
3,665,905
3,728,940
3,668,683
3,628,243
3,581,339
3,623,617
3,591,590
3,613,055
3,802,855
3,885,515
3,887,661
3,807,491
3,794,605
3,794,6053,807,4913,887,6613,885,5153,802,8553,613,0553,591,5903,623,6173,581,3393,628,2433,668,6833,728,9403,665,9053,540,6593,516,2873,505,8013,419,1112,654,5442,606,5922,747,8962,698,7692,586,6162,518,5432,370,9132,287,4012,344,6122,355,6072,425,9812,530,6682,561,1452,585,8192,601,8992,175,6671,981,3582,674,2032,639,7292,449,2642,434,7602,135,9581,064,8241,362,6141,125,4581,094,3181,111,799907,051880,600875,269858,181847,990850,993783,695833,879808,052766,281760,316758,363690,344463,608465,774449,436349,090337,456186,708168,999162,025152,741143,974170,982149,822140,707129,119129,212127,706123,907109,470126,362126,654127,911127,334147,689171,543165,82930,47131,07130,24031,33328,32229,54436,09936,41835,02835,02839,76034,73529,58232,39231,91032,55832,93837,12736,10030,30021,300
       Property Plant Equipment 
8,600
17,000
22,900
25,093
20,743
20,387
20,031
20,715
19,983
22,921
27,996
32,560
32,560
32,704
30,994
28,206
26,338
24,900
23,993
25,154
24,447
27,000
35,620
42,501
41,179
39,556
37,799
37,321
36,251
51,615
52,469
55,466
56,487
58,780
66,249
76,818
95,732
105,199
110,716
124,979
142,252
159,789
182,099
199,141
203,949
212,620
213,755
221,866
217,884
216,496
266,190
268,971
264,317
267,374
273,724
284,473
281,865
282,002
285,664
319,316
437,066
469,862
486,741
523,516
538,117
568,051
604,513
704,207
716,916
724,494
729,836
798,768
824,013
851,097
878,624
896,700
895,392
900,480
924,033
948,682
951,890
962,970
969,300
1,010,868
1,009,972
1,010,917
1,015,062
1,032,471
1,022,474
1,026,579
1,024,787
1,035,461
1,039,544
1,049,464
1,051,821
1,073,366
1,068,142
1,067,278
1,067,156
1,066,133
1,060,425
1,052,898
1,045,408
1,045,4081,052,8981,060,4251,066,1331,067,1561,067,2781,068,1421,073,3661,051,8211,049,4641,039,5441,035,4611,024,7871,026,5791,022,4741,032,4711,015,0621,010,9171,009,9721,010,868969,300962,970951,890948,682924,033900,480895,392896,700878,624851,097824,013798,768729,836724,494716,916704,207604,513568,051538,117523,516486,741469,862437,066319,316285,664282,002281,865284,473273,724267,374264,317268,971266,190216,496217,884221,866213,755212,620203,949199,141182,099159,789142,252124,979110,716105,19995,73276,81866,24958,78056,48755,46652,46951,61536,25137,32137,79939,55641,17942,50135,62027,00024,44725,15423,99324,90026,33828,20630,99432,70432,56032,56027,99622,92119,98320,71520,03120,38720,74325,09322,90017,0008,600
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,250
45,053
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
21,262
23,722
40,360
40,360
53,364
53,364
53,055
53,055
51,543
51,543
51,543
51,543
51,543
51,543
54,975
54,975
54,258
54,258
54,258
54,258
54,258
54,258
202,392
202,392
202,392
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
197,039
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199
196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199196,199197,039197,039197,039197,039197,039197,039197,039197,039197,039197,039197,039197,039197,039197,039197,039197,039197,039202,392202,392202,39254,25854,25854,25854,25854,25854,25854,97554,97551,54351,54351,54351,54351,54351,54353,05553,05553,36453,36440,36040,36023,72221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26221,26245,05332,2500000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
118,085
90,116
129,253
142,511
154,327
146,808
94,944
55,833
123,155
107,589
117,073
124,498
124,906
148,625
268,516
251,928
244,588
449,143
98,895
224,810
509,627
514,381
443,708
314,404
201,620
362,956
572,711
533,628
482,036
416,304
385,785
313,599
279,988
204,883
235,864
320,000
374,965
431,804
411,978
290,796
323,058
265,122
285,473
321,127
350,237
466,618
507,793
462,827
412,503
372,302
333,835
340,635
385,777
548,002
611,135
620,551
557,083
561,985
561,985557,083620,551611,135548,002385,777340,635333,835372,302412,503462,827507,793466,618350,237321,127285,473265,122323,058290,796411,978431,804374,965320,000235,864204,883279,988313,599385,785416,304482,036533,628572,711362,956201,620314,404443,708514,381509,627224,81098,895449,143244,588251,928268,516148,625124,906124,498117,073107,589123,15555,83394,944146,808154,327142,511129,25390,116118,085000000000000000000000000000000000000000000000
       Intangible Assets 
11,400
11,900
11,600
11,462
11,159
10,856
10,345
9,862
9,333
8,868
8,314
0
0
0
0
0
0
0
0
0
0
133,090
131,373
61,504
37,427
37,140
36,854
36,558
14,934
13,841
12,748
11,655
10,563
9,470
8,377
9,596
8,420
7,244
6,068
7,626
6,316
4,391
4,194
40,977
77,416
77,985
104,604
103,648
102,692
101,736
100,780
180,277
170,914
168,267
165,624
162,980
172,016
168,434
165,791
163,147
165,397
163,045
159,949
156,578
926,896
923,861
920,943
683,996
1,177,232
568,966
561,387
553,780
546,172
538,565
530,957
517,510
509,902
502,295
494,687
491,808
485,981
476,632
462,849
456,580
443,717
433,381
427,172
417,271
405,903
394,298
388,487
388,652
374,251
369,368
354,024
338,569
325,989
310,343
302,476
294,701
279,653
265,533
260,920
260,920265,533279,653294,701302,476310,343325,989338,569354,024369,368374,251388,652388,487394,298405,903417,271427,172433,381443,717456,580462,849476,632485,981491,808494,687502,295509,902517,510530,957538,565546,172553,780561,387568,9661,177,232683,996920,943923,861926,896156,578159,949163,045165,397163,147165,791168,434172,016162,980165,624168,267170,914180,277100,780101,736102,692103,648104,60477,98577,41640,9774,1944,3916,3167,6266,0687,2448,4209,5968,3779,47010,56311,65512,74813,84114,93436,55836,85437,14037,42761,504131,373133,09000000000008,3148,8689,3339,86210,34510,85611,15911,46211,60011,90011,400
       Long-term Assets Other 
1,300
1,400
1,600
572
1,036
1,315
1,534
1,815
266
2,946
3,450
2,468
2,468
3,714
5,105
1,338
1,984
6,433
6,247
5,917
6,024
5,739
4,550
43,684
48,728
51,215
52,001
52,483
37,023
37,189
41,227
40,829
40,807
51,195
53,934
63,306
18,560
19,036
23,979
12,584
12,500
12,689
12,578
15,306
14,112
14,558
12,413
14,215
12,227
12,267
13,559
15,495
19,849
20,061
19,739
16,611
15,158
14,883
14,010
143,171
41,545
46,562
61,532
65,281
80,332
58,284
60,790
408,644
25,400
23,057
36,443
32,815
26,580
21,447
22,985
29,852
32,666
39,430
37,565
36,568
96,300
99,456
112,646
122,009
125,918
135,852
119,009
142,237
141,198
141,663
144,705
151,760
149,186
151,797
151,788
176,236
150,057
144,168
165,069
171,538
184,790
180,117
199,314
199,314180,117184,790171,538165,069144,168150,057176,236151,788151,797149,186151,760144,705141,663141,198142,237119,009135,852125,918122,009112,64699,45696,30036,56837,56539,43032,66629,85222,98521,44726,58032,81536,44323,05725,400408,64460,79058,28480,33265,28161,53246,56241,545143,17114,01014,88315,15816,61119,73920,06119,84915,49513,55912,26712,22714,21512,41314,55814,11215,30612,57812,68912,50012,58423,97919,03618,56063,30653,93451,19540,80740,82941,22737,18937,02352,48352,00151,21548,72843,6844,5505,7396,0245,9176,2476,4331,9841,3385,1053,7142,4682,4683,4502,9462661,8151,5341,3151,0365721,6001,4001,300
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
236,017
231,947
228,400
229,172
222,649
221,239
220,593
229,771
225,501
226,757
235,400
238,703
150,391
144,124
147,143
150,991
166,296
163,411
172,545
146,245
220,191
243,212
266,182
288,006
446,786
458,387
470,961
484,759
399,095
407,009
425,380
429,194
460,952
467,333
475,554
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000475,554467,333460,952429,194425,380407,009399,095484,759470,961458,387446,786288,006266,182243,212220,191146,245172,545163,411166,296150,991147,143144,124150,391238,703235,400226,757225,501229,771220,593221,239222,649229,172228,400231,947236,01700000000000000000000000000000000000000000000000
> Total Liabilities 
1,700
34,000
5,700
5,172
4,759
2,894
3,672
6,939
3,684
5,321
6,236
12,263
12,263
11,194
11,259
12,073
17,215
143,948
142,483
138,487
140,524
304,226
298,067
300,944
271,168
277,689
274,221
272,765
442,224
419,827
344,955
345,634
285,050
614,037
616,511
627,553
618,536
628,528
621,137
630,020
626,343
561,003
565,504
594,978
620,965
622,554
658,869
545,366
543,306
548,087
520,537
530,633
525,135
532,101
552,182
585,880
348,141
343,262
344,044
908,176
880,607
883,716
931,991
962,559
1,233,231
1,291,732
1,332,213
1,328,521
1,376,757
1,169,728
1,196,430
1,257,415
1,169,520
1,224,386
1,767,135
1,824,462
1,789,714
1,739,575
1,780,309
1,459,188
1,498,771
1,432,430
1,483,723
1,567,658
1,482,879
2,065,431
2,104,197
1,742,018
1,643,043
1,656,925
1,711,326
1,732,585
1,671,392
1,641,034
1,695,526
1,771,918
1,774,652
1,780,345
1,861,266
1,890,054
1,798,857
1,780,822
1,437,799
1,437,7991,780,8221,798,8571,890,0541,861,2661,780,3451,774,6521,771,9181,695,5261,641,0341,671,3921,732,5851,711,3261,656,9251,643,0431,742,0182,104,1972,065,4311,482,8791,567,6581,483,7231,432,4301,498,7711,459,1881,780,3091,739,5751,789,7141,824,4621,767,1351,224,3861,169,5201,257,4151,196,4301,169,7281,376,7571,328,5211,332,2131,291,7321,233,231962,559931,991883,716880,607908,176344,044343,262348,141585,880552,182532,101525,135530,633520,537548,087543,306545,366658,869622,554620,965594,978565,504561,003626,343630,020621,137628,528618,536627,553616,511614,037285,050345,634344,955419,827442,224272,765274,221277,689271,168300,944298,067304,226140,524138,487142,483143,94817,21512,07311,25911,19412,26312,2636,2365,3213,6846,9393,6722,8944,7595,1725,70034,0001,700
   > Total Current Liabilities 
1,600
7,900
5,600
5,087
4,682
2,826
3,609
6,883
3,637
5,123
6,090
8,302
8,302
7,731
8,347
6,847
12,719
15,251
16,243
12,815
15,161
81,270
75,715
70,054
50,695
43,702
44,224
40,367
56,887
38,004
43,229
46,045
38,829
44,543
49,062
61,543
53,311
63,423
120,735
130,081
126,314
60,033
64,070
78,154
78,699
83,930
92,097
83,844
75,986
82,035
83,254
94,125
119,814
119,997
134,929
170,433
144,008
142,241
167,633
183,271
156,038
166,720
206,550
235,739
305,506
347,704
390,491
445,457
388,011
364,580
377,335
439,310
340,206
374,303
417,529
816,518
773,471
804,950
838,660
523,241
500,986
439,428
493,745
932,503
820,470
813,302
854,693
492,548
430,035
443,344
514,898
539,822
490,418
464,727
521,020
588,884
598,231
597,231
1,163,223
117,702
1,087,900
1,067,337
715,658
715,6581,067,3371,087,900117,7021,163,223597,231598,231588,884521,020464,727490,418539,822514,898443,344430,035492,548854,693813,302820,470932,503493,745439,428500,986523,241838,660804,950773,471816,518417,529374,303340,206439,310377,335364,580388,011445,457390,491347,704305,506235,739206,550166,720156,038183,271167,633142,241144,008170,433134,929119,997119,81494,12583,25482,03575,98683,84492,09783,93078,69978,15464,07060,033126,314130,081120,73563,42353,31161,54349,06244,54338,82946,04543,22938,00456,88740,36744,22443,70250,69570,05475,71581,27015,16112,81516,24315,25112,7196,8478,3477,7318,3028,3026,0905,1233,6376,8833,6092,8264,6825,0875,6007,9001,600
       Short-term Debt 
0
0
0
26
26
29
28
27
29
98
95
1,591
1,591
0
0
0
0
0
0
118,396
0
58,228
48,747
42,805
25,056
12,145
11,696
11,337
27,048
6,705
6,787
6,787
6,786
6,785
6,549
6,309
6,065
5,816
45,193
70,741
70,317
0
0
0
0
0
0
75,620
0
0
0
0
23,455
23,440
23,440
23,365
0
0
0
0
0
0
0
642,902
0
0
0
662,286
0
24,420
22,460
22,478
22,495
676,205
17,430
360,949
365,326
369,752
374,230
0
9,210
10,165
10,225
361,882
365,964
370,100
374,290
11,754
11,227
11,024
9,659
10,464
10,829
10,611
9,226
10,375
9,251
8,294
493,398
502,656
502,931
505,526
15,551
15,551505,526502,931502,656493,3988,2949,25110,3759,22610,61110,82910,4649,65911,02411,22711,754374,290370,100365,964361,88210,22510,1659,2100374,230369,752365,326360,94917,430676,20522,49522,47822,46024,4200662,286000642,902000000023,36523,44023,44023,455000075,62000000070,31770,74145,1935,8166,0656,3096,5496,7856,7866,7876,7876,70527,04811,33711,69612,14525,05642,80548,74758,2280118,3960000001,5911,5919598292728292626000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
642,902
0
0
0
662,286
0
72,238
71,206
22,478
67,759
676,205
1,166,036
360,949
365,326
369,752
374,230
0
6,347
0
0
361,882
365,964
370,100
374,290
0
0
0
0
0
0
0
0
0
0
0
493,398
493,877
494,357
494,837
0
0494,837494,357493,877493,39800000000000374,290370,100365,964361,882006,3470374,230369,752365,326360,9491,166,036676,20567,75922,47871,20672,2380662,286000642,902000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
800
6,000
5,000
3,095
1,367
990
1,792
4,747
1,616
3,049
3,923
4,284
4,284
2,014
763
3,930
9,532
12,123
13,399
10,098
2,299
840
466
946
2,470
2,324
539
484
440
231
1,498
2,285
748
754
1,313
1,169
2,326
2,847
2,029
58,851
5,178
31,012
2,076
7,567
3,276
9,708
7,184
4,956
5,274
7,252
7,107
12,239
12,439
12,501
11,459
147,068
144,008
142,241
167,633
95,302
156,038
166,720
206,550
235,739
230,212
256,330
296,200
392,511
290,562
292,342
306,129
370,505
135,604
158,229
364,920
401,921
346,538
358,732
378,226
437,290
412,830
429,502
483,745
570,621
454,506
443,202
218,021
191,429
399,225
411,132
203,321
193,003
187,810
199,251
207,165
231,238
264,778
277,944
301,369
315,509
292,238
257,412
312,321
312,321257,412292,238315,509301,369277,944264,778231,238207,165199,251187,810193,003203,321411,132399,225191,429218,021443,202454,506570,621483,745429,502412,830437,290378,226358,732346,538401,921364,920158,229135,604370,505306,129292,342290,562392,511296,200256,330230,212235,739206,550166,720156,03895,302167,633142,241144,008147,06811,45912,50112,43912,2397,1077,2525,2744,9567,1849,7083,2767,5672,07631,0125,17858,8512,0292,8472,3261,1691,3137547482,2851,4982314404845392,3242,4709464668402,29910,09813,39912,1239,5323,9307632,0144,2844,2843,9233,0491,6164,7471,7929901,3673,0955,0006,000800
       Other Current Liabilities 
800
1,900
600
1,966
3,289
1,807
1,789
2,109
1,992
1,976
2,072
2,427
229
5,717
7,584
2,917
3,187
3,128
2,844
2,717
12,862
9,821
7,843
1,903
2,286
19,391
22,397
20,450
19,506
22,842
27,702
29,881
24,141
29,850
34,561
48,738
40,041
51,524
72,070
182
50,699
28,092
61,845
78,068
75,265
74,222
84,913
3,056
70,712
74,783
76,147
81,886
79,627
82,614
98,946
77,847
72,195
69,926
89,095
87,969
72,811
62,934
86,093
98,991
75,294
91,374
94,291
52,946
97,449
47,818
48,746
46,327
45,264
216,074
52,609
53,648
61,607
76,466
86,204
85,951
88,156
9,926
10,000
-13,037
-7,889
-5,350
259,142
289,213
30,810
32,212
48,187
329,399
291,473
254,560
304,214
346,560
324,202
597,231
669,825
351,588
281,509
283,623
371,891
371,891283,623281,509351,588669,825597,231324,202346,560304,214254,560291,473329,39948,18732,21230,810289,213259,142-5,350-7,889-13,03710,0009,92688,15685,95186,20476,46661,60753,64852,609216,07445,26446,32748,74647,81897,44952,94694,29191,37475,29498,99186,09362,93472,81187,96989,09569,92672,19577,84798,94682,61479,62781,88676,14774,78370,7123,05684,91374,22275,26578,06861,84528,09250,69918272,07051,52440,04148,73834,56129,85024,14129,88127,70222,84219,50620,45022,39719,3912,2861,9037,8439,82112,8622,7172,8443,1283,1872,9177,5845,7172292,4272,0721,9761,9922,1091,7891,8073,2891,9666001,900800
   > Long-term Liabilities 
100
26,100
100
85
77
68
63
56
47
198
146
3,961
3,961
3,463
2,912
5,226
4,496
128,697
126,240
125,672
125,363
222,956
222,352
230,890
220,473
233,987
229,997
232,398
385,337
381,823
301,726
299,589
246,221
569,494
567,449
566,010
565,225
565,105
500,402
499,939
500,029
500,970
501,434
516,824
542,266
538,624
566,772
461,522
467,320
466,052
437,283
436,508
405,321
412,104
417,253
415,447
204,133
201,021
176,411
724,905
724,569
716,996
725,441
726,820
927,725
944,028
941,722
883,064
988,746
805,148
819,095
818,105
829,314
850,083
1,349,606
1,007,944
1,016,243
934,625
941,649
935,947
997,785
993,002
989,978
635,155
662,409
1,252,129
1,249,504
1,249,470
1,213,008
1,213,581
1,196,428
1,192,763
1,180,974
1,176,307
1,174,506
1,183,034
1,176,421
1,183,114
698,043
713,030
710,957
713,485
722,141
722,141713,485710,957713,030698,0431,183,1141,176,4211,183,0341,174,5061,176,3071,180,9741,192,7631,196,4281,213,5811,213,0081,249,4701,249,5041,252,129662,409635,155989,978993,002997,785935,947941,649934,6251,016,2431,007,9441,349,606850,083829,314818,105819,095805,148988,746883,064941,722944,028927,725726,820725,441716,996724,569724,905176,411201,021204,133415,447417,253412,104405,321436,508437,283466,052467,320461,522566,772538,624542,266516,824501,434500,970500,029499,939500,402565,105565,225566,010567,449569,494246,221299,589301,726381,823385,337232,398229,997233,987220,473230,890222,352222,956125,363125,672126,240128,6974,4965,2262,9123,4633,9613,96114619847566368778510026,100100
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
497,083
497,083
377,521
377,521
377,520
348,339
348,329
324,872
324,865
324,861
324,859
109,849
109,822
78,310
655,566
661,419
650,872
656,884
657,976
655,491
661,492
667,793
662,286
668,009
645,685
653,178
660,761
668,437
676,205
1,166,036
813,521
817,672
821,871
826,119
830,417
834,766
839,165
853,160
486,238
486,713
1,073,202
1,074,164
1,075,145
1,076,127
1,077,110
1,078,093
1,079,077
1,080,061
1,081,047
1,082,033
0
1,084,006
1,084,994
0
0
0
0
0
000001,084,9941,084,00601,082,0331,081,0471,080,0611,079,0771,078,0931,077,1101,076,1271,075,1451,074,1641,073,202486,713486,238853,160839,165834,766830,417826,119821,871817,672813,5211,166,036676,205668,437660,761653,178645,685668,009662,286667,793661,492655,491657,976656,884650,872661,419655,56678,310109,822109,849324,859324,861324,865324,872348,329348,339377,520377,521377,521497,083497,083000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
236,017
231,947
228,400
229,172
222,649
221,239
220,593
229,771
225,501
226,757
235,400
238,703
150,391
144,124
147,143
150,991
166,296
163,411
172,545
146,245
220,191
243,212
266,182
288,006
446,786
458,387
470,961
484,759
399,095
407,009
425,380
429,194
460,952
467,333
475,554
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000475,554467,333460,952429,194425,380407,009399,095484,759470,961458,387446,786288,006266,182243,212220,191146,245172,545163,411166,296150,991147,143144,124150,391238,703235,400226,757225,501229,771220,593221,239222,649229,172228,400231,947236,01700000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,843
1,816
3,697
1,240
0
363
704
290
2,852
3,049
18,022
15,550
19,476
17,501
14,512
8,642
7,101
5,776
4,787
3,128
2,082
1,769
1,917
3,162
2,586
2,724
3,708
4,218
17,196
28,700
25,100
42,552
47,484
53,282
52,015
52,427
53,052
47,751
54,541
59,694
57,292
56,763
54,017
60,911
69,339
63,150
66,124
68,557
68,844
79,032
89,334
80,727
77,251
177,210
159,463
165,917
157,344
160,877
173,878
183,570
194,423
198,571
112,754
115,530
105,530
115,068
99,958
91,319
98,117
175,696
132,099
129,939
174,325
136,881
136,471
118,335
113,686
100,913
95,260
92,473
73,502
92,415
0
105,457
0
0
0
0
0000105,457092,41573,50292,47395,260100,913113,686118,335136,471136,881174,325129,939132,099175,69698,11791,31999,958115,068105,530115,530112,754198,571194,423183,570173,878160,877157,344165,917159,463177,21077,25180,72789,33479,03268,84468,55766,12463,15069,33960,91154,01756,76357,29259,69454,54147,75153,05252,42752,01553,28247,48442,55225,10028,70017,1964,2183,7082,7242,5863,1621,9171,7692,0823,1284,7875,7767,1018,64214,51217,50119,47615,55018,0223,0492,85229070436301,2403,6971,8161,843000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,296
37,521
37,182
37,190
0
0
0
0
0
193,202
193,202
193,202
143,527
143,527
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000143,527143,527193,202193,202193,2020000037,19037,18237,52133,2960000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
25,100
17,400
106,800
98,377
89,731
83,196
79,652
69,994
61,759
93,000
84,166
159,548
159,548
130,779
116,210
98,543
165,902
162,437
141,963
117,853
98,772
43,190
14,163
-67,978
-90,235
-110,442
-65,379
-77,462
46,005
48,887
122,117
117,802
164,714
167,602
174,545
187,726
209,166
226,027
237,901
276,675
273,940
283,434
303,853
322,185
345,240
362,962
585,664
717,257
720,840
732,305
774,539
773,048
771,950
1,000,426
1,015,194
1,015,763
1,250,152
1,258,258
1,276,486
1,341,041
1,460,121
1,461,969
1,508,442
1,527,894
2,425,455
2,356,957
2,292,640
2,400,847
2,290,236
1,917,576
2,645,808
2,766,275
2,769,087
2,795,579
2,813,562
2,808,663
2,807,003
2,885,104
2,914,945
2,967,940
2,936,627
2,960,954
3,074,405
3,122,381
3,239,962
3,236,679
4,053,893
4,106,002
4,162,010
4,241,571
4,266,149
4,270,740
4,391,315
4,504,807
4,568,514
4,603,156
4,659,043
4,782,827
4,896,897
4,951,549
5,073,816
5,286,299
5,413,396
5,413,3965,286,2995,073,8164,951,5494,896,8974,782,8274,659,0434,603,1564,568,5144,504,8074,391,3154,270,7404,266,1494,241,5714,162,0104,106,0024,053,8933,236,6793,239,9623,122,3813,074,4052,960,9542,936,6272,967,9402,914,9452,885,1042,807,0032,808,6632,813,5622,795,5792,769,0872,766,2752,645,8081,917,5762,290,2362,400,8472,292,6402,356,9572,425,4551,527,8941,508,4421,461,9691,460,1211,341,0411,276,4861,258,2581,250,1521,015,7631,015,1941,000,426771,950773,048774,539732,305720,840717,257585,664362,962345,240322,185303,853283,434273,940276,675237,901226,027209,166187,726174,545167,602164,714117,802122,11748,88746,005-77,462-65,379-110,442-90,235-67,97814,16343,19098,772117,853141,963162,437165,90298,543116,210130,779159,548159,54884,16693,00061,75969,99479,65283,19689,73198,377106,80017,40025,100
   Common Stock
0
0
0
35
35
35
37
37
37
42
42
52
52
53
54
54
63
64
64
64
64
64
64
65
65
65
74
75
85
85
91
92
96
96
97
97
98
99
100
100
100
100
101
101
102
102
103
111
111
112
114
115
116
123
124
126
139
140
142
144
146
147
148
149
161
161
162
162
163
164
173
173
173
175
176
176
177
178
178
178
179
179
180
180
181
181
181
182
183
183
184
184
185
186
186
186
188
188
188
189
190
190
191
1911901901891881881881861861861851841841831831821811811811801801791791781781781771761761751731731731641631621621611611491481471461441421401391261241231161151141121111111031021021011011001001001009998979796969291858575746565656464646464646354545352524242373737353535000
   Retained Earnings -319,638-425,718-532,892-621,554-641,929-682,307-738,347-789,199-788,949-777,227-804,891-925,689-867,791-831,297-844,238-861,609-883,708-1,668,511-1,639,328-1,720,709-1,735,733-1,790,769-1,753,334-1,694,134-1,690,475-1,677,855-1,661,063-1,637,548-1,586,156-1,573,629-1,536,796-1,520,506-1,573,068-1,530,271-1,106,711-1,021,569-1,090,186-999,260-917,271-849,770-779,973-787,418-753,916-715,801-653,811-600,791-579,258-539,448-486,436-481,079-449,073-425,101-398,366-380,713-375,636-371,265-359,076-576,410-575,933-577,084-581,795-588,436-589,748-576,596-601,102-601,931-605,741-607,427-609,997-604,781-600,917-591,624-581,233-574,197-572,871-563,091-548,095-532,619-511,279-488,821-406,399-376,921-321,323-301,378-275,651-254,360-245,263-225,580-206,250-189,133-148,119-148,119-113,197-102,182-90,213-80,513-70,119-61,970-54,884-43,149-34,100-26,500-19,600
   Accumulated Other Comprehensive Income 
-6,000
-5,800
-5,400
-5,101
-4,832
-4,510
-3,422
-3,470
-3,285
2,033
2,217
-14,248
2,385
3,046
3,996
5,031
5,043
5,128
5,195
5,057
5,102
-530
-260
-363
-235
-144
-16
-16
-15
-49
-24
-25
-5
-7
128
139
351
-575
-2,754
1,106
2,069
101
-704
933
4,405
10,224
-1,581
188
-5,787
-5,923
1,304
4,887
2,512
4,650
2,333
-202
1,155
2,441
11,473
5,018
7,275
9,941
19,189
27,466
43,819
32,461
25,184
21,033
47
4,528
2,158
12,816
5,020
-14,658
-21,434
-22,961
-28,545
-1,129
-2,160
5,271
19,794
17,439
37,003
20,164
34,127
30,050
10,385
-16,139
5,004
-939
10,239
14,432
-877
18,472
30,749
-3,867
-10,722
-18,617
6,257
-28,788
-12,746
15,126
4,650
4,65015,126-12,746-28,7886,257-18,617-10,722-3,86730,74918,472-87714,43210,239-9395,004-16,13910,38530,05034,12720,16437,00317,43919,7945,271-2,160-1,129-28,545-22,961-21,434-14,6585,02012,8162,1584,5284721,03325,18432,46143,81927,46619,1899,9417,2755,01811,4732,4411,155-2022,3334,6502,5124,8871,304-5,923-5,787188-1,58110,2244,405933-7041012,0691,106-2,754-575351139128-7-5-25-24-49-15-16-16-144-235-363-260-5305,1025,0575,1955,1285,0435,0313,9963,0462,385-14,2482,2172,033-3,285-3,470-3,422-4,510-4,832-5,101-5,400-5,800-6,000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
931,361
948,394
1,090,188
1,103,885
1,122,732
1,175,422
1,197,082
1,221,933
1,483,336
1,505,776
1,561,890
1,833,831
1,863,961
1,926,133
2,059,101
2,213,347
2,249,445
2,278,761
2,359,744
3,308,137
3,337,503
3,371,377
3,414,837
3,410,297
3,458,124
4,231,514
4,288,113
4,314,793
4,397,980
4,435,449
4,483,220
4,510,451
4,577,300
4,620,817
4,669,926
4,682,900
4,744,316
4,782,916
4,832,707
4,854,814
4,885,637
4,937,791
4,993,407
5,010,619
5,083,831
5,133,742
5,191,502
5,206,287
5,272,666
5,335,853
0
5,417,873
5,493,956
0
0
0
0
0
000005,493,9565,417,87305,335,8535,272,6665,206,2875,191,5025,133,7425,083,8315,010,6194,993,4074,937,7914,885,6374,854,8144,832,7074,782,9164,744,3164,682,9004,669,9264,620,8174,577,3004,510,4514,483,2204,435,4494,397,9804,314,7934,288,1134,231,5143,458,1243,410,2973,414,8373,371,3773,337,5033,308,1372,359,7442,278,7612,249,4452,213,3472,059,1011,926,1331,863,9611,833,8311,561,8901,505,7761,483,3361,221,9331,197,0821,175,4221,122,7321,103,8851,090,188948,394931,361000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
50,700
49,700
146,300
145,863
149,097
149,641
153,156
153,940
155,220
193,107
195,104
0
305,230
316,813
318,410
319,038
406,059
411,605
412,355
414,110
414,929
420,577
420,758
421,141
421,214
422,256
482,658
485,570
618,806
623,048
703,283
709,359
765,540
772,294
784,317
794,917
814,458
828,434
841,657
852,065
861,519
871,669
886,251
898,235
916,666
929,046
946,218
1,088,223
1,102,152
1,118,829
1,171,487
1,193,147
1,218,395
1,476,732
1,499,173
1,555,287
1,828,116
1,856,468
1,918,682
2,051,680
2,206,616
2,239,299
2,269,078
2,350,049
3,298,746
3,323,595
3,357,480
3,401,221
3,396,737
3,443,155
4,216,545
4,273,792
4,300,690
4,383,691
4,420,976
4,468,996
4,496,434
4,563,910
4,607,402
4,656,625
4,669,988
4,734,105
4,772,955
4,822,746
4,844,982
4,874,959
4,927,035
4,983,568
5,001,061
5,073,624
5,123,517
5,181,813
5,196,898
5,263,376
5,326,528
5,396,036
5,407,924
5,483,563
5,532,381
5,601,702
5,607,564
5,696,701
5,728,193
5,728,1935,696,7015,607,5645,601,7025,532,3815,483,5635,407,9245,396,0365,326,5285,263,3765,196,8985,181,8135,123,5175,073,6245,001,0614,983,5684,927,0354,874,9594,844,9824,822,7464,772,9554,734,1054,669,9884,656,6254,607,4024,563,9104,496,4344,468,9964,420,9764,383,6914,300,6904,273,7924,216,5453,443,1553,396,7373,401,2213,357,4803,323,5953,298,7462,350,0492,269,0782,239,2992,206,6162,051,6801,918,6821,856,4681,828,1161,555,2871,499,1731,476,7321,218,3951,193,1471,171,4871,118,8291,102,1521,088,223946,218929,046916,666898,235886,251871,669861,519852,065841,657828,434814,458794,917784,317772,294765,540709,359703,283623,048618,806485,570482,658422,256421,214421,141420,758420,577414,929414,110412,355411,605406,059319,038318,410316,813305,2300195,104193,107155,220153,940153,156149,641149,097145,863146,30049,70050,700



5.4. Balance Sheets

Currency in USD. All numbers in thousands.